O4.08 AGI5198, AN INHIBITOR OF IDH1R132H, PROTECTS IDH1R132H HCT116 CELLS AGAINST IRRADIATION

BACKGROUND: IDH1R132H mutations are both inaugural events in the formation of glioma and associated with prolonged glioma patient survival. The IDH1R132H mutation confers a neo-enzymatic function that results in accumulation of the oncometabolite D-2-hydroxyglutarate (D-2HG), which promotes gliomage...

Full description

Saved in:
Bibliographic Details
Published inNeuro-oncology (Charlottesville, Va.) Vol. 16; no. suppl 2; pp. ii8 - ii9
Main Authors Molenaar, R. J., Dimitrakopoulou, D., Stap, J., Bleeker, F. E., Van Noorden, C. J. F.
Format Journal Article
LanguageEnglish
Published 01.09.2014
Subjects
Online AccessGet full text

Cover

Loading…